Primary cerebral lymphoma--a case report and review of the management.
The brain is an uncommon extranodal site for the development of malignant lymphoma. There is an increased risk among immunocompromised patients. While the overall outcome is poor, innovative approaches with combination chemotherapy and radiotherapy can sometimes produce durable remissions. The treatment of a non-immunocompromised patient with cerebral lymphoma incorporating chemotherapy and radiotherapy is described with a review of the literature.
Li
Q
Q
Department of Medical Oncology, Singapore General Hospital.
Ang
P T
PT
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002528:Cerebellar Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000532:radiotherapy; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone